Galera Therapeutics' Series B - II Round

Galera Therapeutics raised a round of funding on February 03, 2016. Investors include Enso Ventures.

Galera Therapeutics is a clinical-stage biotechnology company, headquartered in Malvern, PA, focused on the development of drugs targeting oxygen metabolic pathways. The Company's lead compounds are h…

Articles about Galera Therapeutics' Series B - II Round: